Long-term outcomes of Japan-specific dosage of rivaroxaban in high-risk patients with non-valvular atrial fibrillation: analysis from the XAPASS
28 August 2020 (08:00 - 18:00)
Organised by:
Abstract
Slides
About the speaker
Toho University, Tokyo (Japan)
172 More presentations in this session
Doctor J. Sousa (Funchal, PT)
Doctor A. Lyon (Maastricht, NL)
Mr M. Nazarzadeh (Oxford, GB)
Access the full session
The Event
ESC Congress 2020
28 August 2020
08:00 CET
You may be interested in
Congress Session
Congress Presentation
